Proprietary topical compounded formulations offer the promise of significantly reducing the number of patient eye drop administrations as well as the high cost of eye drops typically required for traditional treatment
Results of an investigator-initiated evaluation of the company's Pred-Moxi and Tri-Moxi topical eye drops for patients following LASIK surgery expected to be announced by end of January 2015 SAN DIEGO , Jan.
Fourth quarter revenue of $33.6 million, an increase of 15.5% from the year-ago quarter on a preliminary, unaudited basis Fourth quarter revenue exceeds top-end of company's guidance range
Display Corporation (Nasdaq: OLED), enabling energy-efficient
displays and lighting with its UniversalPHOLED ®
technology and materials, announced today that Sidney Rosenblatt,
Executive Vice President and Chief Financial Officer, will participate
in a question-and-answer session at the 17 th Annual Needham
Growth Conference in New York City on Tuesday, January 13, 2015 at 12:45
p.m. Eastern Time.
Trading Symbols: TSX: CRJ; OTCQB: CLGRF Highlights:
Record annual gold production of 62,984 ounces, a 44% increase from 2013 Annual mill head grade of 7.32 grams per tonne, a 43% increase from 2013 Santoy Gap development completed ahead of schedule and long-hole mining initiated in Q3 2014 Year-end cash and cash equivalents position of approximately $11.2 million Total debt reduction of $10.6 million during 2014 2015 gold production guidance of 60,000 to 65,000 ounces SASKATOON , Jan.
Digi International ® Inc. (NASDAQ:DGII, www.digi.com )
will release financial results for its fiscal first quarter 2015 on
Thursday, January 22, 2015, after market close, and will host a
conference call later the same day, at 5:00 p.m. ET (4:00 p.m. CT), to
discuss the results.
Drinks company Constellation Brands Inc. (STZ) said Thursday it had net income of $248 million, or $1.10 a share, in its fiscal third quarter, with the net income number up 5% from the same period a year ago.
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration
company focused on advanced wound and burn care, introduces financial
guidance for the year ended December 31, 2015 and provides preliminary
net sales for the year ended December 31, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.